Multiple endocrine neoplasia 2A (MEN 2A) is an autosomal dominant disease that consists of medullary thyroid carcinoma (MTC), pheochromocytoma and parathyroid hyperplasia. The activation of germ-line mutations in the RET proto-oncogene are responsible for MEN 2A. We describe here a rare case of MEN 2A in a patient who presented with an acute catecholamine-induced cardiomyopathy with cardiogenic shock and acute renal failure. The patient was diagnosed with pheochromocytoma and MTC associated with MEN 2A, which was confirmed by the detection of a RET proto-oncogene mutation at exon 11 on codon 634 (Cys634Arg). During familial screening, the patient's younger sister was found to have a benign thyroid nodule. Re-evaluation of this thyroid nodule revealed MTC with the same gene mutation. We also provide a review of the relevant literature. (Endocrinol Metab 25:135-141, 2010) 
INTRODUCTION
Multiple endocrine neoplasia (MEN) type 2A is an autosomal dominant condition characterized by the development of medullary thyroid cancer (MTC), pheochromocytoma, and parathyroid hyperplasia. In 1993, Mulligan et al. [1] reported that MEN 2A could be traced to a germline mutation in the RET gene. The development of pheochromocytoma in 80% of patients with MEN 2A is due to mutations in codon 634 [2] . Pheochromocytoma is usually diagnosed at the same time as MTC and is the first sign of MEN 2A in 9-27% of cases [3] . Between 30% and 50% of pheochromocytomas in MEN 2A patients are asymptomatic [3, 4] , given that the tumors are diagnosed by screening. However, pheochromocytoma presenting as fatal cardiogenic shock is a recognized and relatively uncommon occurrence, with only a few cases reported [5] .
In this rare case, we diagnosed pheochromocytoma presenting with symptoms of acute heart failure and pulmonary edema due to catecholamine-induced cardiomyopathy. We subsequently diagnosed MTC in the patient's thyroid nodules. We confirmed that the patient had a mutation of C634R in exon 11. Based on our findings, the patient's family members underwent screening tests and RET gene tests for MEN 2A. In a younger sister of the patient, who was undergoing follow-up observations for benign thyroid nodules at a private clinic, the same mutation was noted, and MTC was also identified. We report our findings regarding this family and provide a review of the relevant literature. An oval-shaped solid mass was detected in each of the thyroid lobes, and histopathological examination confirmed the diagnosis of MTC (Fig. 5) . The presence of normal parathyroid glands was confirmed during surgery.
With the consent of the patient and family members, we performed genetic studies to determine whether or not germline mutations of RET genes were responsible for MEN 2A. Genomic DNA was extracted from peripheral blood using the Wizard Genomic DNA Purification Kit (Takara, Japan). Automatic nucleotide sequence analysis was performed for exons 10, 11, 13, and 14. In the patient, we identified a point mutation where TGC (cysteine) was replaced by CGC (arginine) at codon 634 in exon 11 of the RET gene; the patient's younger sister had the same mutation. Genetic testing of the patient's family members, including her mother, brother, and another sister, did not reveal any abnormal findings suggestive of genetic mutations (Fig. 6 ). Fig. 3 . Histology of the resected thyroid gland. A. Total thyroidectomy specimen was measured to be 9 × 5 cm in size and 25 g in weight. A cut section showed multiple yellow/brown variable-sized nodules. The left thyroid showed a well-defined yellowish mass measuring 1.5 × 1 cm. The right thyroid showed a well-demarcated dark brown mass measuring 2 × 1.5 cm. B. Microscopic finding of medullary thyroid carcinoma showed multiple rather well-defined tumor nodules consisting of nests or clusters of tumor cells with dense fibrous to hyalinized stroma (H&E stain, × 100). [6] . Pheochromocytoma manifests a broad spectrum of clinical symptoms and signs, ranging from asymptom-atic presentation to paroxysmal hypertension, sweating, and palpitations due to excitation of sympathetic nerves [7] . However, as was the case for the patient in our study, the clinical symptoms of heart failure accompanied by acute pulmonary edema are not commonly observed [7] . Pheochromocytoma should also be included in the differential diagnosis of acute coronary syndrome, because acute catecholamine secretion may induce chest pain and abnormal ECG changes mimicking acute myocardial infarction, especially in young patients with low cardiovascular risk [8] . Tumor necrosis caused by ischemia secondary to vasoconstriction and a massive release of catecholamines also contribute to initial hypertension as well as subsequent hypotension and myocardial damage [9] . Unusual findings of ST-segment depression on EKG and other findings on echocardiography can be misinterpreted as an acute ischemic heart disease due to atherosclerotic coronary artery disease. Likewise, cardiac diseases caused by pheochromocytoma are not easily diagnosed because the high dose of catecholamines released from a pheochromocytoma promotes myocardial metabolism and induces the constriction of coronary arteries [8] . Most MEN patients have no significant coronary atherosclerosis, in contrast to cases of classic myocardial infarction [10] . In addition, acute renal failure may be caused by intense renal vasoconstriction induced by catecholamines and cardiovascular shock [11] . In our case, we inferred that an acute spontaneous hemorrhage within the tumor mass led to a massive release of catecholamines (as demonstrated by pathological findings), which resulted in acute heart failure and pulmonary edema that led to subsequent cardiogenic shock and acute renal failure due to ischemic injury. Pheochromocytomas in MEN 2 patients do not secrete catecholamines as readily or as continuously, and have a high capacity to synthesize hormones, especially adrenaline [12, 13] . So, the major symptom is more paroxysmal than chronic, and other minor symptoms are less frequent than in the sporadic cases. Fortunately enough, our presented case did not have any of the typical symptoms at curs; otherwise, the resulting acute crisis may be fatal [8] .
A genotype-phenotype relationship has been demonstrated be-
Fig. 5.
Histology of the resected thyroid gland in younger sister of the patient. A. The total thyroidectomy specimen measured 34 g. The left thyroid was 5 × 3 × 3 cm in size, and a cut surface showed multinodular gray/white masses measuring 4 × 3 cm. The right thyroid was 3 × 3 × 2 cm in size, and a cut surface showed a gray/white nodular mass measuring 1.5 × 1 cm. B. Microscopic findings of the thyroid medullary carcinoma showed ill-defined tumor tissue consisting of proliferating round to polygonal cells with granular amphophilic cytoplasm and medium-sized nuclei separated by a vascular stroma, hyalinized collagen, and amyloid tissue arranged in a follicular and trabecular pattern. Associated calcification was evident (H&E stain, × 100). At the present time, FNA is the standard diagnostic test for identification of thyroid nodules, and the accuracy of FNA tests for thyroid cancer is 90% [19] . In cases of papillary cancer, the accuracy of FNA diagnosis reaches approximately 93%, but it is only 79% with respect to correct diagnosis of medullary cancer [19] . In this case, the patient's thyroid nodule had been identified as a benign follicular nodule on FNA, but increased levels of serum calcitonin were noted. Thus, we suspected medullary thyroid carcinoma, the diagnosis of which was confirmed at surgery. Therefore, when managing a patient with a thyroid nodule, a thorough inspection of family history is important. In cases where MTC is clinically suspected, meticulous laboratory studies including serum calcitonin levels is necessary.
SUMMARY
We suspected the presence of pheochromocytoma and were able to confirm our diagnosis in a patient presenting with symp- 
